BNTX logo

BioNTech SE (BNTX) Company Overview

Profile

Full Name:

BioNTech SE

Sector:

Healthcare

Industry:

Biotechnology

Country:

Germany

IPO:

October 10, 2019

Indexes:

Not included

Website:

http://www.biontech.de

Description:

BioNTech SE is a biotechnology company based in Germany. It focuses on developing innovative therapies and vaccines, especially for cancer and infectious diseases. BioNTech gained fame for its COVID-19 vaccine, created in partnership with Pfizer, using mRNA technology to help the immune system fight viruses.

Key Details

Price

$112.83

Market Cap

$27.05 B(Large cap)

Last Dividend

$2.13

TTM Dividend Yield

-

Annual Revenue

$4.13 B(-77.35% YoY)

Annual EPS

$4.15(-89.59% YoY)

PE Ratio

-

Annual ROE

4.59%

Annual Debt To Equity

0.01

Beta

-

Events Calendar

Earnings

Next earnings date:

Mar 10, 2025

Recent quarterly earnings:

Nov 4, 2024

Recent annual earnings:

Mar 20, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jun 2, 2022
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 10, 25 Truist Securities
Buy
Dec 11, 24 Wells Fargo
Overweight
Nov 27, 24 Canaccord Genuity
Buy
Nov 26, 24 JP Morgan
Neutral
Nov 19, 24 Evercore ISI Group
Outperform
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Canaccord Genuity
Buy
Nov 14, 24 Canaccord Genuity
Buy
Nov 8, 24 Goldman Sachs
Buy
Nov 6, 24 TD Cowen
Hold

Screeners with BNTX included

Growing Shares Outstanding
Best performing stocks last 5 years
Healthcare sector
All stocks
High Altman Z score stocks
NASDAQ Listed Companies
Biotechnology industry
Earnings next week
Large cap stocks
Stocks above SMA 200

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$112.83
BNTX price is $112.83

Price All-time High

$447.23
BNTX price is currently -74.77% below its historical high of $447.23

Price Analysts Target

-
BNTX price consensus analysts' forecast is unknown

Price Most Recent Change

-0.15%
BNTX price was down -0.15% on Mar 8, 2025

Price YTD Change

0%
BNTX {parameterFullLabel} has remained unchanged since January 1st

Price 3-Year Change

-10.63%
BNTX price is down -10.63% over the past 3 years

Market cap

Market Cap

$27.05 B
BNTX market capitalization is $27.05 billion

Market Cap 3-Year Change

-11.65%
BNTX market capitalization is down -11.65% over the past 3 years

Market Cap All-time High

$108.46 B
BNTX market capitalization is currently -75.06% below its historical high of $108.46 billion

Market Cap Sector Rank

96.21%
BNTX market capitalization is higher than 96.21% of companies in Healthcare sector

Technical

Beta

-
BNTX beta value is unknown

200-day SMA

$104.78
BNTX price is currently +7.68% above its 200-day simple moving average

14-day RSI

-
BNTX 14-day relative strength index value is unknown

30-day Relative Volume

1.71
BNTX 30-day relative volume is 1.71

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$2.13
BNTX last dividend was $2.13 per share, with an ex-dividend date of June 2, 2022

Next Dividend

-
BNTX next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
BNTX annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
BNTX annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
BNTX annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
BNTX annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
BNTX annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
BNTX annual dividend yield is unknown

Other

Annual Payout Ratio

0.00%
BNTX annual payout ratio is 0.00%

Annual Dividends Paid

$0.00
BNTX annual dividends paid is $0.00

Annual FCF

$5.05 B
BNTX annual free cash flow is $5.05 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$4.13 B
BNTX annual revenue is $4.13 billion

Annual Revenue Analysts Estimate

$2.65 B
BNTX annual revenue is currently +56.15% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-77.35%
BNTX annual revenue is down -77.35% year-on-year

Annual Revenue Sector Rank

91.21%
BNTX annual revenue is higher than 91.21% of companies in Healthcare sector

Profit

Annual Gross Profit

$3.49 B
BNTX annual gross profit is $3.49 billion

Annual Gross Margin

84.29%
BNTX annual gross profit margin is 84.29%

Annual Operating Profit

$978.90 M
BNTX annual operating income is $978.90 million

Annual Operating Margin

23.68%
BNTX annual operating profit margin is 23.68%

Annual Net Income

$1.01 B
BNTX annual net profit is $1.01 billion

Annual Net Margin

24.36%
BNTX annual net profit margin is 24.36%

EPS

Annual EPS

$4.15
BNTX annual earnings per share is $4.15

Annual EPS Analysts Estimate

-$3.28
BNTX annual earnings per share is currently -226.35% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-89.59%
BNTX annual earnings per share is down -89.59% year-on-year

Annual EPS Sector Rank

94.55%
BNTX annual earnings per share is higher than 94.55% of companies in Healthcare sector

ROA & ROE

Annual ROA

4.00%
BNTX annual return on assets is 4.00%

Annual ROE

4.59%
BNTX annual return on equity is 4.59%

EBIT & EBITDA

Annual EBIT

$978.90 M
BNTX annual earnings before interest & taxes is $978.90 million

Annual EBITDA

$1.18 B
BNTX annual EBITDA is $1.18 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
BNTX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
BNTX price to earnings ratio is unknown

PB Ratio

PB Ratio

1.27
BNTX price to book ratio is 1.27

PB Ratio Sector Rank

48.19%
BNTX price to book ratio is higher than 48.19% of companies in Healthcare sector

PS Ratio

PS Ratio

8.19
BNTX price to sales ratio is 8.19

PS Ratio Sector Rank

74.19%
BNTX price to sales ratio is higher than 74.19% of companies in Healthcare sector

Enterprise value

Enterprise Value

$16.57 B
BNTX enterprise value is $16.57 billion

Enterprise Value Sector Rank

94.27%
BNTX enterprise value is higher than 94.27% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-41.75
BNTX EV/EBITDA is -41.75

EV/EBITDA Sector Rank

3.42%
BNTX EV/EBITDA is higher than 3.42% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

9.43
BNTX annual current ratio is 9.43

Annual Quick Ratio

9.26
BNTX annual quick ratio is 9.26

Leverage

Annual Debt To Equity

0.01
BNTX annual debt to equity ratio is 0.01

Annual Interest Coverage Ratio

-
BNTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
BNTX piotroski f-score is 3

Altman Z-Score

7.72
BNTX altman z-score is 7.72

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$25.43 B
BNTX annual total assets is $25.43 billion

Annual Non Current Assets

$3.85 B
BNTX annual long term assets is $3.85 billion

Annual Current Assets

$21.59 B
BNTX annual total current assets is $21.59 billion

Annual Cash & Cash Equivalents

$12.89 B
BNTX annual cash & cash equivalents is $12.89 billion

Equity

Annual Book Value

$22.38 B
BNTX annual book value is $22.38 billion

Annual Working Capital

$19.30 B
BNTX annual working capital is $19.30 billion

Liabilities

Annual Total Liabilities

$3.05 B
BNTX annual total liabilities is $3.05 billion

Annual Total Long Term Liabilities

$762.62 M
BNTX annual total long term liabilities is $762.62 million

Annual Current Liabilities

$2.29 B
BNTX annual total current liabilities is $2.29 billion

Annual Accounts Payable

$391.31 M
BNTX annual accounts payable is $391.31 million

Debt

Annual Total Debt

$242.19 M
BNTX annual total debt is $242.19 million

Annual Total Debt 1-Year Change

+6.43%
BNTX annual total debt is up +6.43% year-on-year

Annual Long Term Debt

$211.13 M
BNTX annual long term debt is $211.13 million

Annual Short Term Debt

$31.06 M
BNTX annual short term debt is $31.06 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$3.16 B
BNTX annual total expenses is $3.16 billion

Annual Operating Expenses

$2.51 B
BNTX annual total operating expenses is $2.51 billion

Annual Cost Of Goods Sold

$649.35 M
BNTX annual cost of goods sold is $649.35 million

Annual SGA

$603.77 M
BNTX annual SGA is $603.77 million

Annual D&A

$198.55 M
BNTX annual depreciation & amortization is $198.55 million

Annual Interest Expense

-
BNTX annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$5.82 B
BNTX annual cash flow from operations is $5.82 billion

Annual CFO 1-Year Change

-59.39%
BNTX annual cash flow from operations is down -59.39% year-on-year

Annual CFI

-$7.53 B
BNTX annual cash flow from investing activities is -$7.53 billion

Annual CFI 1-Year Change

-20124.47%
BNTX annual cash flow from investing activities is down -20124.47% year-on-year

Annual CFF

-$842.92 M
BNTX annual cash flow from financing activities is -$842.92 million

Annual CFF 1-Year Change

+43.68%
BNTX annual cash flow from financing activities is up +43.68% year-on-year

Free CashFlow

Annual FCF

$5.05 B
BNTX annual free cash flow is $5.05 billion

Annual FCF 1-Year Change

-63.75%
BNTX annual free cash flow is down -63.75% year-on-year

CAPEX

Annual CAPEX

$763.78 M
BNTX annual capital expenditures is $763.78 million

Annual CAPEX 1-Year Change

+99.35%
BNTX annual capital expenditures is up +99.35% year-on-year

Institutional Ownership

Similar stocks

MTD logo
Mettler-Toledo International (MTD)
BGNE logo
BeiGene (BGNE)
HZNP logo
Horizon Therapeutics Public Limited (HZNP)
BeiGene (ONC)
PHG logo
Koninklijke Philips NV (PHG)
DXCM logo
DexCom (DXCM)
CNC logo
Centene (CNC)
CAH logo
Cardinal Health (CAH)
WAT logo
Waters (WAT)

FAQ

  • What is the ticker symbol for BioNTech SE?
  • Does BioNTech SE pay dividends?
  • What sector is BioNTech SE in?
  • What industry is BioNTech SE in?
  • What country is BioNTech SE based in?
  • When did BioNTech SE go public?
  • Is BioNTech SE in the S&P 500?
  • Is BioNTech SE in the NASDAQ 100?
  • Is BioNTech SE in the Dow Jones?
  • When was BioNTech SE's last earnings report?
  • When does BioNTech SE report earnings?

What is the ticker symbol for BioNTech SE?

The ticker symbol for BioNTech SE is NASDAQ:BNTX

Does BioNTech SE pay dividends?

No, BioNTech SE does not pay dividends

What sector is BioNTech SE in?

BioNTech SE is in the Healthcare sector

What industry is BioNTech SE in?

BioNTech SE is in the Biotechnology industry

What country is BioNTech SE based in?

BioNTech SE is headquartered in Germany

When did BioNTech SE go public?

BioNTech SE's initial public offering (IPO) was on October 10, 2019

Is BioNTech SE in the S&P 500?

No, BioNTech SE is not included in the S&P 500 index

Is BioNTech SE in the NASDAQ 100?

No, BioNTech SE is not included in the NASDAQ 100 index

Is BioNTech SE in the Dow Jones?

No, BioNTech SE is not included in the Dow Jones index

When was BioNTech SE's last earnings report?

BioNTech SE's most recent earnings report was on Nov 4, 2024

When does BioNTech SE report earnings?

The next expected earnings date for BioNTech SE is Mar 10, 2025